- Home
- HURA vs CVRX Comparison
HURA vs CVRX Comparison
Compare HURA & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HURA | CVRX |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.4M | 160.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HURA | CVRX |
|---|---|---|
| Price | $2.52 | $4.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $9.50 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 479.8K | 241.9K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $0.41 | $4.37 |
| 52 Week High | $3.90 | $11.30 |
Technical Indicators
Market Signals| Indicator | HURA | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 35.60 |
| Support Level | $2.38 | $4.37 |
| Resistance Level | $2.68 | $5.95 |
| Average True Range (ATR) | 0.18 | 0.34 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 99.89 | 13.56 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.